Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in bharat biotech

Bharat Biotech, IVI Launch Chikungunya Vaccine Phase 2/3 Trial In Costa Rica

The funding is supported by the European Union’s (EU’s) Horizon 2020 programme through an existing framework partnership agreement with CEPI.

Read More

India Has Done Better Than Any Country Across World In Vaccination: Bharat Biotech CMD

The prime minister also lauded those involved in vaccine manufacturing in the country and said India did not have to depend on the outside world for vaccines against the coronavirus.

Read More

Govt Approves Bharat Biotech's Ankleshwar Plant To Produce Covaxin: Mandaviya

The approval would help increase availability of COVID-19 vaccines in the country, he added.

Read More

Bharat Biotech's Rotavac 5D Receives WHO Prequalification

WHO Prequalification enables the procurement of Rotavac 5D by agencies such as UNICEF and PAHO (Pan American Health Organisation) and will fast-track global access to this life saving vaccine.

Read More

Bharat Biotech Scraps Mou With Brazilian Partners After Graft Allegations

Bharat Biotech signed a MoU with Precisa Medicamentos and Envixia Pharmaceuticals LL.C on November 20 for the purpose of introducing Covaxin in the territory of Brazil.

Read More

11% Of India's Covid-19 Cases Reported In Persons Aged Below 20: Govt

The outcome of these trials will depend on data emerging from the trial for the purpose of its approval and availability in the country

Read More

Bharat Biotech's Partner Ocugen Seeks Approval For Covaxin In Canada

Health Canada will make a decision upon review of the evidence submitted that supports its safety, efficacy and quality.

Read More

Documents For Covaxin Emergency Use Listing Submitted To WHO; Expect Approval At Earliest: Bharat Biotech

EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.

Read More

Ocugen Pays USD 15 Mn Upfront To Bharat Biotech For Covaxin Rights In Canada

Ocugen in a regulatory filing said it has agreed to pay another USD 10 million to Bharat Biotech within a month from the commercial launch of Covaxin in the North American country.

Read More

Bharat Biotech S Pact With Ocugen For Covaxin Expanded To Canada

Bharat Biotech on February 2 said it andOcugenInc a US-based biopharmaceutical companyhave entered into a definitive agreement to co-develop, supply, and commercialise

Read More

Indian Immunologiclas To Start Drug Substance Production For Covaxin From June

The technology transfer process was well underway and IILhas the capabilities and expertise to manufacture inactivated viral vaccines at commercial scale and under biosafety containment

Read More

Bharat Biotech's US Partner Ocugen Submits 'Master File' To FDA On Covaxin

Ocugen has submitted key information and data to date including preclinical studies, chemistry, manufacturing, and controls (CMC), and clinical studies as a Master File for FDA review and input prior to a planned EUA submission.

Read More

Bharat Biotech Submitted 90% Of Documents To WHO For Emergency Use Listing For Covaxin: Sources

The company is in the final stages of negotiations with the Food and Drug Administration of the US for conducting small-scale phase-III clinical trials of Covaxin in the United States

Read More

COVAXIN Production Volumes Ramped Up To 200 Million By Bharat Biotech

The company plans to produce 200 million doses of COVAXIN per annum in the good manufacturing practice (GMP) facilities that are already operational for the production of vaccines based on Inactivated Vero Cell Platform Technology,

Read More

Bharat Biotech To Ramp Up Covaxin Production By Additional 200 Million Doses

Chiron Behring Vaccines, a 100 per cent subsidiary of Bharat Biotech, is one of the largest manufacturers of rabies vaccines in the world.

Read More